Emlozin 10 mg (Tablet)
Unit Price: ৳ 25.00 (2 x 15: ৳ 750.00)
Strip Price: ৳ 375.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Team pharmaceuticals ltd |
| Also available as |
Title
- Emlozin 10 mg Tablet
Categories
- Diabetes Medication
- Cardiovascular Disease Medication
Description
- Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus
- Reduction of cardiovascular death risk in adult patients with type 2 diabetes mellitus and established cardiovascular disease
- SGLT-2 inhibitor
- Recommended dosage of 10 mg once daily, can be increased to 25 mg once daily
- Contraindicated in patients with severe renal impairment, end-stage renal disease, or history of serious hypersensitivity reaction
- Common side effects: urinary tract infections, female genital mycotic infections, dehydration, hypotension, weakness, dizziness, increased thirstiness
- Should not be initiated in patients with an eGFR less than 45 ml/min/1.73 m^2
- Storage conditions: Keep in a cool & dry place (below 30°C), protected from light & moisture, keep out of the reach of children
Indications
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Pharmacology
- SGLT2 co-transporters inhibition leads to reduced renal absorption of glucose, increased glucose excretion, reduced hyperglycemia, weight loss, and reduced blood pressure
Dosage administration
- Recommended dose of 10 mg once daily, taken in the morning, with or without food
- Dose may be increased to 25 mg once daily in patients tolerating the medication
Interactions
- Co-administration with diuretics resulted in increased urine volume
- Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia
- Monitoring glycemic control with urine glucose tests is not recommended due to increased urinary glucose excretion
- Monitoring glycemic control with 1,5-AG assay is not recommended as measurements are unreliable in patients taking SGLT2 inhibitors
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy lactation
- Use during pregnancy only if the potential benefit justifies the potential risk to the fetus
- Not recommended when breastfeeding
Precautions warnings
- Assessment of renal function is recommended prior to initiation and periodically thereafter
- Not initiated in patients with an eGFR less than 45 ml/min/1.73 m^2
- No dose adjustment needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m^2
Overdose effects
- Usual supportive measures should be employed
- Removal of Emlozin by hemodialysis has not been studied
Therapeutic class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage conditions
- Keep in a cool & dry place (below 30°C), protected from light & moisture, keep out of the reach of children
Chemical structure
- Molecular Formula: C23H27ClO7
- Chemical Structure image available
Commonly asked questions
- What is Emlozin 10 mg Tablet?
- What is Emlozin 10 mg Tablet used for?
- Are there any pregnancy warnings?
- Are there any breast-feeding warnings?
- Does this affect kidney function?
- Does this affect liver function?
- Quick Tips: Usage, dehydration, hypoglycemia, hygiene, monitoring, symptoms